{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:07:52Z","timestamp":1792098472237,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ijrobp.2016.01.027","type":"journal-article","created":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T20:18:13Z","timestamp":1453493893000},"page":"712-720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Intensity Modulated Radiation Therapy for Early-Stage Primary Gastric Diffuse Large B-Cell Lymphoma: Dosimetric Analysis, Clinical Outcome, and Quality of Life"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5953-0212","authenticated-orcid":false,"given":"Xin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1345-8339","authenticated-orcid":false,"given":"Yong-Wen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Lian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Xiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2016.01.027_bib1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1023\/A:1008282818705","article-title":"Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas","volume":"8","author":"Zucca","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1746-1596-6-77","article-title":"Subtype distribution of lymphomas in Southwest China: Analysis of 6,382 cases using WHO classification in a single institution","volume":"6","author":"Yang","year":"2011","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib3","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1200\/JCO.2001.19.18.3861","article-title":"Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01\/92","volume":"19","author":"Koch","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib4","doi-asserted-by":"publisher","first-page":"7050","DOI":"10.1200\/JCO.2005.04.031","article-title":"Treatment results in localized primary gastric lymphoma: Data of patients registered within the German multicenter study (GIT NHL 02\/96)","volume":"23","author":"Koch","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S1470-2045(06)70664-7","article-title":"CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: A randomised controlled trial by the MabThera International Trial (MInT) Group","volume":"7","author":"Pfreundschuh","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib7","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1200\/JCO.2009.27.3441","article-title":"Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy","volume":"28","author":"Phan","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib8","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1200\/JCO.2013.51.4505","article-title":"Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma","volume":"32","author":"Held","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib9","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1200\/JCO.2015.61.7654","article-title":"Treatment selection and survival outcomes in early-stage diffuse large B-cell lymphoma: Do we still need consolidative radiotherapy?","volume":"33","author":"Vargo","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib10","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s00277-012-1512-4","article-title":"The comparison between CHOP and R-CHOP in primary gastric diffuse large B cell lymphoma","volume":"91","author":"Sohn","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00277-011-1306-0","article-title":"Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: A multicenter study of 95 patients in Japan","volume":"91","author":"Tanaka","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib12","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.3109\/10428194.2012.680451","article-title":"Rituximab in treatment of primary gastric diffuse large B-cell lymphoma","volume":"53","author":"Zhang","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib13","doi-asserted-by":"publisher","first-page":"e0133469","DOI":"10.1371\/journal.pone.0133469","article-title":"Consolidation radiotherapy in stage IE-IIE, non-bulky primary gastric diffuse large B-cell lymphoma with post-chemotherapy complete remission","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ijrobp.2011.11.008","article-title":"Dosimetric and clinical outcomes of involved-field intensity-modulated radiotherapy after chemotherapy for early-stage Hodgkin's lymphoma with mediastinal involvement","volume":"84","author":"Lu","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib15","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.ijrobp.2013.08.040","article-title":"High-dose and extended-field intensity modulated radiation therapy for early-stage NK\/T-cell lymphoma of Waldeyer's ring: Dosimetric analysis and clinical outcome","volume":"87","author":"Bi","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib16","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.ijrobp.2012.10.037","article-title":"Dosimetric evaluation and treatment outcome of intensity modulated radiation therapy after doxorubicin-based chemotherapy for primary mediastinal large B-cell lymphoma","volume":"85","author":"Xu","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib17","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.ijrobp.2004.10.025","article-title":"Radiation treatment planning techniques for lymphoma of the stomach","volume":"62","author":"Della Biancia","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib18","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1093\/jrr\/rru052","article-title":"Radiotherapy for gastric lymphoma: A planning study of 3D conformal radiotherapy, the half-beam method, and intensity-modulated radiotherapy","volume":"55","author":"Inaba","year":"2014","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib19","first-page":"554","article-title":"High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma","volume":"91","author":"Marcucci","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib20","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/cncr.22549","article-title":"High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers","volume":"109","author":"Wang","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib21","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1093\/annonc\/mdq583","article-title":"Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: Meta-analysis and examination of FDA safety reports","volume":"22","author":"Evens","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"Suppl. 3","key":"10.1016\/j.ijrobp.2016.01.027_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3171\/jns.2000.93.supplement_3.0219","article-title":"A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note","volume":"93","author":"Paddick","year":"2000","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib24","first-page":"34","article-title":"ICRU report 83: Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT)","volume":"10","year":"2010","journal-title":"J ICRU"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib26","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S0959-8049(00)00417-2","article-title":"Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer","volume":"37","author":"Vickery","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib27","series-title":"EORTC QLQ-C30 Scoring Manual","first-page":"6","author":"Fayers","year":"2001"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib28","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ijrobp.2003.11.003","article-title":"Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: Toxicity and clinical outcome","volume":"59","author":"Milano","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib29","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.ijrobp.2008.12.036","article-title":"Combined adjuvant radiochemotherapy with IMRT\/XELOX improves outcome with low renal toxicity in gastric cancer","volume":"75","author":"Boda-Heggemann","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/1748-717X-8-207","article-title":"Intensity modulated radiotherapy of upper abdominal malignancies: Dosimetric comparison with 3D conformal radiotherapy and acute toxicity","volume":"8","author":"Nour","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib31","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.ijrobp.2005.03.013","article-title":"IMRT for adjuvant radiation in gastric cancer: A preferred plan?","volume":"63","author":"Ringash","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib32","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1002\/cncr.25246","article-title":"Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer","volume":"116","author":"Minn","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib33","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1080\/10428190902912478","article-title":"Early stage gastric diffuse large B-cell lymphomas: Results of a randomized trial comparing chemotherapy alone versus chemotherapy + involved field radiotherapy. (IELSG 4). [corrected]","volume":"50","author":"Martinelli","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib34","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1200\/JCO.2006.05.5897","article-title":"Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma","volume":"24","author":"van Imhoff","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib35","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.leukres.2007.03.017","article-title":"The GCB subtype of diffuse large B-cell lymphoma is less frequent in Asian countries","volume":"31","author":"Shiozawa","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib36","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12253-012-9585-x","article-title":"Correlation between immunophenotype classification and clinicopathological features in Chinese patients with primary gastric diffuse large B-cell lymphoma","volume":"19","author":"Zizhen","year":"2013","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib37","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1200\/JCO.2007.15.9277","article-title":"Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma","volume":"26","author":"Fu","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.01.027_bib38","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1001\/jama.2014.15704","article-title":"Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: A randomized clinical trial","volume":"312","author":"Huang","year":"2014","journal-title":"JAMA"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301616000481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301616000481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T19:16:34Z","timestamp":1567538194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301616000481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0360301616000481"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2016.01.027","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intensity Modulated Radiation Therapy for Early-Stage Primary Gastric Diffuse Large B-Cell Lymphoma: Dosimetric Analysis, Clinical Outcome, and Quality of Life","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2016.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}